Does TRIPTORELIN Cause Interstitial lung disease? 11 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Interstitial lung disease have been filed in association with TRIPTORELIN (TRIPTODUR). This represents 0.2% of all adverse event reports for TRIPTORELIN.
11
Reports of Interstitial lung disease with TRIPTORELIN
0.2%
of all TRIPTORELIN reports
0
Deaths
2
Hospitalizations
How Dangerous Is Interstitial lung disease From TRIPTORELIN?
Of the 11 reports, 2 (18.2%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for TRIPTORELIN.
What Other Side Effects Does TRIPTORELIN Cause?
Off label use (545)
Death (362)
Ovarian hyperstimulation syndrome (356)
Needle issue (242)
Disease progression (203)
Product dose omission issue (178)
Drug ineffective (175)
Weight increased (167)
Hot flush (153)
Headache (145)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which TRIPTORELIN Alternatives Have Lower Interstitial lung disease Risk?
TRIPTORELIN vs TRISODIUM
TRIPTORELIN vs TROFINETIDE
TRIPTORELIN vs TROFOSFAMIDE
TRIPTORELIN vs TROPATEPINE
TRIPTORELIN vs TROPICAMIDE